Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,527 Hepatitis
clinical trials

Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Veterans Affairs Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Froedtert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Options Health Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Island View Gastroenterology Associates
mi
from
Ventura, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Tulane University Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Consultants for Clinical Research of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
HCV Infection Clinical Trial
Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Helping Empower Liver and Kidney Patients
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Impact of Hepatitis C Therapy and Bone Health
Status: Enrolling, Phase IV
Updated: 3/1/2018
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Maryland, Institute of Human Virology
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Research Institute
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
South Denver Gastroenterology
mi
from
Englewood, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Pennsylvania State University and Milton s. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Liver Associates of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Grand Teton Research Group
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Palmtree Clinical Research Inc
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Hospital and Clinics
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Nashville, TN
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Newark, NJ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Richmond, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Wilmington, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Associates in Gastroenterology
mi
from
Hermitage, TN
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Entecavir to TAF Switch
Status: Enrolling, Phase III
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hepatitis B, Chronic Clinical Trial
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Texas Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
St Joseph's Comprehensive Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Whitman Walker Health
mi
from
Washington DC,
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
George Washington University
mi
from
Washington DC,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers
Status: Enrolling, Phase
Updated: 12/31/1969
Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton s-Tyrosine Kinase Inhibitor (BTK-I)
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Autoimmune Hepatitis Clinical Trial
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Durham, NC
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Hospital and Clinics
mi
from
Miami, FL
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Associates Research Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Piedmont Atlanta Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
Silicon Valley Research Institute
mi
from
San Jose, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Colorado Hospital CRS (6101)
mi
from
Aurora, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ. of Cincinnati CRS (2401)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
Ucsd, Avrc Crs (701)
mi
from
San Diego, CA
Click here to add this to my saved trials
Hepatitis Delta Virus Clinical Trial
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Hepatitis Delta Virus Clinical Trial
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale University Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Hepatitis Delta Virus Clinical Trial
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Sooner Research
mi
from
Norman, OK
Click here to add this to my saved trials
Hepatitis Delta Virus Clinical Trial
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Hepatitis Delta Virus Clinical Trial
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Medical Center - Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors
Status: Enrolling, Phase III
Updated: 12/31/1969
Centerpoint Medical Center LLC
mi
from
Independence, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors
Status: Enrolling, Phase III
Updated: 12/31/1969
Minimally Invasive Surgery Hospital
mi
from
Lenexa, KS
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Status: Enrolling, Phase
Updated: 12/31/1969
Registry Coordinating Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Status: Enrolling, Phase
Updated: 12/31/1969
Veterans Affairs Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Metropolitan Research
mi
from
Annandale, VA
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Scpmg/ Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Alabama Liver & Digestive Specialists (Alds)
mi
from
Montgomery, AL
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling, Phase II
Updated: 12/2/2013
Options Health Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Hepatitis B Research Network Adult Cohort Study
Status: Enrolling, Phase
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Hepatitis B Research Network Adult Cohort Study
Status: Enrolling, Phase
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Status: Enrolling, Phase I, II
Updated: 10/14/2015
UCSD Antiviral Research Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 7/23/2012
Virginia
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 7/23/2012
Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 7/23/2012
New York
mi
from
Manhasset, NY
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 7/23/2012
Oregon
mi
from
Portland, OR
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 7/23/2012
DC
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Status: Enrolling
Updated: 10/18/2012
Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Status: Enrolling
Updated: 10/18/2012
Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Status: Enrolling
Updated: 10/18/2012
Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
Hepatitis C Clinical Trial
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling, Phase
Updated: 12/31/1969
MetaClin Research, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 … 15